Supernus Pharmaceuticals (SUPN) EPS (Basic) (2011 - 2025)
Supernus Pharmaceuticals (SUPN) reported EPS (Basic) of -$0.07 for Q4 2025, down 125.0% year-over-year from $0.28 in Q4 2024, and up 91.25% quarter-over-quarter from -$0.8 in Q3 2025.
Supernus Pharmaceuticals (SUPN) EPS (Basic) (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 15 years of EPS (Basic) data on file, last reported at -$0.07 in Q4 2025.
- EPS (Basic) for Q4 2025 came in at -$0.07, down 125.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.47 (down 141.59% YoY), and the FY2025 annual result was -$0.68, down 150.75% from the prior year.
- EPS (Basic) improved to -$0.07 in Q4 2025 per SUPN's latest filing, from -$0.8 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.7 in Q3 2024 and troughed at -$0.8 in Q3 2025.
- A 5-year average of $0.14 and a median of $0.13 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 1900.0% in 2024, then plunged 9380.94% in 2025.
- A 5-year view of EPS (Basic) shows it stood at $0.05 in 2021, then soared by 840.0% to $0.47 in 2022, then tumbled by 95.74% to $0.02 in 2023, then jumped by 1300.0% to $0.28 in 2024, then tumbled by 125.0% to -$0.07 in 2025.
- Business Quant data shows SUPN's EPS (Basic) at -$0.07 in Q4 2025, -$0.8 in Q3 2025, and $0.4 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.83 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.80 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.47 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.45 |
| Mar 31, 2021 | 0.11 |